Tekla Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Tekla Capital Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$20.5M	Sell	179,437 -106,216	-37%	-$12.2M	0.8%	35
2023 Q1	$39.4M	Buy	285,653 +144,694	+103%	+$19.9M	1.5%	21
2022 Q4	$18.3M	Sell	140,959 -25,000	-15%	-$3.24M	0.69%	38
2022 Q3	$18.3M	Sell	165,959 -46,206	-22%	-$5.11M	0.75%	37
2022 Q2	$15.9M	Sell	212,165 -15,532	-7%	-$1.16M	0.63%	42
2022 Q1	$17.8M	Sell	227,697 -88,200	-28%	-$6.89M	0.62%	43
2021 Q4	$28.4M	Sell	315,897 -110,617	-26%	-$9.96M	0.92%	34
2021 Q3	$39.4M	Buy	426,514 +233,290	+121%	+$21.6M	1.27%	23
2021 Q2	$15M	Buy	193,224 +64,237	+50%	+$4.99M	0.49%	52
2021 Q1	$9.61M	Sell	128,987 -77,500	-38%	-$5.78M	0.33%	77
2020 Q4	$35.2M	Hold	206,487	–	–	1.24%	20
2020 Q3	$29M	Buy	206,487 +66,358	+47%	+$9.32M	1.09%	22
2020 Q2	$22.5M	Hold	140,129	–	–	0.86%	28
2020 Q1	$13.7M	Sell	140,129 -41,494	-23%	-$4.06M	0.62%	38
2019 Q4	$23.4M	Buy	181,623 +41,344	+29%	+$5.34M	0.89%	28
2019 Q3	$10.6M	Sell	140,279 -7,568	-5%	-$570K	0.46%	54
2019 Q2	$22.5M	Hold	147,847	–	–	0.92%	28
2019 Q1	$17.6M	Sell	147,847 -43,990	-23%	-$5.24M	0.72%	35
2018 Q4	$20.9M	Sell	191,837 -31,345	-14%	-$3.42M	0.9%	28
2018 Q3	$36M	Sell	223,182 -11,307	-5%	-$1.83M	1.31%	19
2018 Q2	$31M	Sell	234,489 -144,027	-38%	-$19M	1.18%	23
2018 Q1	$28M	Buy	378,516 +44,116	+13%	+$3.27M	1.09%	25
2017 Q4	$18.6M	Sell	334,400 -202,200	-38%	-$11.3M	0.72%	34
2017 Q3	$24.3M	Buy	536,600 +25,000	+5%	+$1.13M	0.87%	28
2017 Q2	$17.2M	Hold	511,600	–	–	0.64%	35
2017 Q1	$15.1M	Buy	511,600 +45,300	+10%	+$1.34M	0.59%	35
2016 Q4	$12.8M	Buy	466,300 +252,200	+118%	+$6.92M	0.54%	41
2016 Q3	$13.1M	Buy	+214,100	New	+$13.1M	0.51%	47
2015 Q2	–	Sell	-230,300	Closed	-$3.06M	–	114
2015 Q1	$3.06M	Sell	230,300 -115,100	-33%	-$1.53M	0.12%	84
2014 Q4	$5M	Hold	345,400	–	–	0.23%	73
2014 Q3	$7.29M	Buy	+345,400	New	+$7.29M	0.34%	60